Affiliation:
1. Lepetit S.p.A., 20124 Milan, Italy
Abstract
The mechanism of action of rifampicin, an antibiotic which inhibits in vitro the polycondensation of ribonucleotides by ribonucleic acid (RNA) nucleotidyltransferase, was studied in vivo in
Escherichia coli
. It is argued that the inhibition of RNA nucleotidyltransferase represents the primary lesion and is responsible for the bactericidal effect. This conclusion is based on (i) the correlation between concentrations of the antibiotic which block in vivo incorporation of labeled uracil and the bactericidal concentrations, (ii) the evidence that the loss of viability of the cells immediately follows the block of RNA synthesis, and (iii) the observation that the reversal of the inhibition of RNA synthesis goes together with a reversal of the loss of viability.
Publisher
American Society for Microbiology
Subject
Molecular Biology,Microbiology
Reference9 articles.
1. Rifampicin: a new rifamycin. I. Bacteriological studies;Arioli V.;Arzneimittel-Forsch.,1967
2. Mutants of E. coli requiring methionine or vitamin B12;Davis B. D.;J. Bacteriol.,1950
3. The specific inhibition of the DNA-directed RNA synthesis by rifamycin;Hartmann G.;Biochim. Biophys. Acta,1967
4. Hurwitz C. 1964. Mechanism of action of streptomycin. Antimicrobial Agents and Chemotherapy-1963 p. 371-386.
5. Maal 0e O. and N. 0. Kieldgaard. 1966. Control of macromolecular synthesis. W. A. Benjamin Inc. New York.
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献